Patent · US Active

Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells

US8338170B2 · kind B2 · utility

59Cited by
34References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 21, 2008
Grant dateDec 25, 2012
Priority date
Expiry dateMay 24, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2506/02
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure relates to compositions and methods comprising cell surface markers for hES-derived cells, in particular, endoderm lineage cells including pancreatic endoderm-type cells, derived from hES cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.